Entorhinal Cortex Layer Ii Neurons In Alzheimer'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Layer II neurons of the entorhinal cortex (EC-II) are the gateway neurons connecting the hippocampus to the neocortex. These neurons are critically affected in early Alzheimer's disease and represent one of the first sites of tau pathology spread.
EC-II neurons are projection neurons that:
- Form the perforant path input to the dentate gyrus
- Integrate spatial and olfactory information
- Bridge neocortical association areas with hippocampal formation
- Support episodic memory encoding
EC-II is uniquely vulnerable because:
- It's an early site of neurofibrillary tangle formation
- It's a major hub for cortical connectivity
- It has high metabolic demands
- It receives extensive cortical inputs
EC-II shows some of the earliest tau changes:
- Neurofibrillary tangles appear in Braak stage I/II
- Tau pathology precedes amyloid deposition in this region
- Pre-neurofibrillary tangle changes in cholinergic neurons
Structural changes include:
- Significant neuronal loss in EC-II
- Atrophy of layer II neuronal soma
- Dendritic degeneration
- Reduced perforant path signaling
EC-II neurons may serve as conduits for tau spreading:
- High connectivity facilitates trans-synaptic transmission
- Tau pathology spreads to hippocampus via perforant path
- Vulnerability increases with aging
EC-II neurons face unique metabolic challenges:
- High energy demands for synaptic transmission
- Reliance on glucose metabolism
- Vulnerability to oxidative stress
- Impaired mitochondrial function
EC-II changes provide early AD markers:
- CSF tau elevation reflects EC-II pathology
- Structural MRI shows early entorhinal atrophy
- FDG-PET reveals hypometabolism
Monitoring EC-II integrity:
- Entorhinal thickness predicts conversion from MCI to AD
- EC atrophy correlates with memory deficits
- Tau PET shows early EC binding
Potential interventions:
- Early tau aggregation inhibitors
- Neurotrophic factor delivery
- Metabolic support strategies
- Synaptic protective agents
The study of Entorhinal Cortex Layer Ii Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Braak & Braak (1991). Neuropathological staging of AD-related changes. Acta Neuropathologica
- Van Hoesen et al. (1991). Entorhinal cortex pathology in AD. Hippocampus
- Kahn et al. (2022). EC-II vulnerability in early AD. Nature Neuroscience